Trial Profile
Phase IIb trial of obeticholic acid in patients with secondary bile acid diarrhoea (sBAD) due to Crohn's disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2014
Price :
$35
*
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Crohn's disease; Diarrhoea
- Focus Therapeutic Use
- 30 Jan 2014 New trial record
- 09 Jan 2014 Intercept Pharmaceuticals expects to initiate this trial in the second half of 2014, according to a media release.